Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis

doi:10.5497/wjp.v7.i1.1

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 1

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (12554)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-2) series, Tables (1-1) series.

Item

Count

PDF

558

WORD

291

HTML

6681

Figures (1-2)

251

Tables (1-1)

198

Sum=7979

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

1203

Download

1453

Sum=2656

Publishing Process of This Article

Item

Count

Browse

879

Download

1040

Sum=1919

Oct 22, 2018 (publication date) through Apr 24, 2024

Times Cited of This Article

Times Cited (10)

Journal Information of This Article

Publication Name

World Journal of Pharmacology

ISSN

2220-3192

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Editorial

World J Pharmacology. Oct 22, 2018; 7(1): 1-9
Published online Oct 22, 2018. doi: 10.5497/wjp.v7.i1.1

Table 1 Examples of current pharmacological treatments of fibromyalgia[40,46]

Drug class	Drug
Tricyclic antidepressants	Amitriptyline
Serotonin-noradrenaline re-uptake inhibitors	Duloxetine
Serotonin-noradrenaline re-uptake inhibitors	Milnacipran
Selective serotonin re-uptake inhibitor	Fluoxetine
Selective serotonin re-uptake inhibitor	Citalopram
Dopamine receptor agonist	Pramipexole
α2delta	Gabapentin
α2delta	Pregabalin
Analgesics	Dihydrocodeine
	Morphine
	Tramadol
	Paracetamol

Citation: Lawson K. Kv7 channels a potential therapeutic target in fibromyalgia: A hypothesis. World J Pharmacology 2018; 7(1): 1-9
URL: https://www.wjgnet.com/2220-3192/full/v7/i1/1.htm
DOI: https://dx.doi.org/10.5497/wjp.v7.i1.1